Clinical trial NCT05324033 - References

Cancer, Bladder — Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

Citation(s)

•   Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B
  Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2020 Apr;203(4):706-712. doi: 10.1097/JU.0000000000000617. Epub 2019 Oct 23.
•   Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP
  Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015 Jun;67(6):1042-1050. doi: 10.1016/j.eururo.2014.11.043. Epub 2014 Dec 8.
•   Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM
  Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26. Erratum In: J Urol. 2017 Nov;198(5):1175.
•   Chavhan, G
  (2013). MRI Made Easy (for beginners) (2nd ed., pp. 2-16). JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD.
•   Cheung G, Sahai A, Billia M, Dasgupta P, Khan MS
  Recent advances in the diagnosis and treatment of bladder cancer. BMC Med. 2013 Jan 17;11:13. doi: 10.1186/1741-7015-11-13.
•   DeGeorge KC, Holt HR, Hodges SC
  Bladder Cancer: Diagnosis and Treatment. Am Fam Physician. 2017 Oct 15;96(8):507-514.
•   Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V
  Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5.
•   Ghai S, Haider MA
  Multiparametric-MRI in diagnosis of prostate cancer. Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606.
•   Hawkes RC, Holland GN, Moore WS, Worthington BS
  Nuclear magnetic resonance (NMR) tomography of the brain: a preliminary clinical assessment with demonstration of pathology. J Comput Assist Tomogr. 1980 Oct;4(5):577-86. doi: 10.1097/00004728-198010000-00001.
•   Huang L, Kong Q, Liu Z, Wang J, Kang Z, Zhu Y
  The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. Radiology. 2018 Feb;286(2):502-511. doi: 10.1148/radiol.2017171028. Epub 2017 Dec 4.
•   Kagawa T, Yoshida S, Shiraishi T et al
  , Basic principles of magnetic resonance imaging for beginner oral and maxillofacial radiologists. Oral Radiol 33, 92-100 (2017).
•   Kelly, C
  R., & Landman, J. (2012, March 29). The Netter Collection of Medical Illustrations - Urinary System. saunders elsevier.
•   Margel D, Alkhateeb SS, Finelli A, Fleshner N
  Diminished efficacy of Bacille Calmette-Guerin among elderly patients with nonmuscle invasive bladder cancer. Urology. 2011 Oct;78(4):848-54. doi: 10.1016/j.urology.2011.04.070. Epub 2011 Aug 16.
•   Nikolaev A, Knipe H, Bell D
  (2020). Vesical Imaging-Reporting and Data System (VI-RADS) | Radiology Reference Article | Radiopaedia.org. Vesical Imaging-Reporting and Data System (VI-RADS) | Radiology Reference Article | Radiopaedia.org. Retrieved January 27, 2023, from https://radiopaedia.org/articles/vesical-imaging-reporting-and-data-system-vi-rads-2
•   Oeyen E, Hoekx L, De Wachter S, Baldewijns M, Ameye F, Mertens I
  Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles. Int J Mol Sci. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821.
•   Petralia G, Summers PE, Agostini A, Ambrosini R, Cianci R, Cristel G, Calistri L, Colagrande S
  Dynamic contrast-enhanced MRI in oncology: how we do it. Radiol Med. 2020 Dec;125(12):1288-1300. doi: 10.1007/s11547-020-01220-z. Epub 2020 May 15.
•   Shampo MA, Kyle RA, Steensma DP
  Richard Ernst--Nobel Prize for nuclear magnetic resonance spectroscopy. Mayo Clin Proc. 2012 Dec;87(12):e109. doi: 10.1016/j.mayocp.2012.01.023. No abstract available.
•   Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH
  The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010 Feb;105(3):300-8. doi: 10.1111/j.1464-410X.2009.09076.x. Epub 2009 Nov 13.
•   Standring, S
  , Anand, N., Birch, R., Collins, P., Crossman, A., & Gleeson , M. (2016). Anatomy GRAY'S The Anatomical Basis of Clinical Practice (41st ed., pp. 1254-1313). Elsevier Limited
•   Wang H, Luo C, Zhang F, Guan J, Li S, Yao H, Chen J, Luo J, Chen L, Guo Y
  Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. Radiology. 2019 Jun;291(3):668-674. doi: 10.1148/radiol.2019182506. Epub 2019 Apr 23.
•   Westbrook, C
  , Roth, C., & Talbot, J. (2011). MRI in Practice (4th ed., pp. 397-403). A John Wiley & Sons, Ltd., Publication.
•   Withey SJ, Christodoulou D, Prezzi D, Rottenberg G, Sit C, Ul-Hassan F, Carroll P, Velusamy A, Izatt L, Nair R, Jacques AET
  Bladder paragangliomas: a pictorial review. Abdom Radiol (NY). 2022 Apr;47(4):1414-1424. doi: 10.1007/s00261-022-03443-2. Epub 2022 Feb 14.
•   Woo S, Suh CH, Kim SY, Cho JY, Kim SH
  Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis. Eur J Radiol. 2017 Oct;95:46-55. doi: 10.1016/j.ejrad.2017.07.021. Epub 2017 Jul 29.
•   Zhu CZ, Ting HN, Ng KH, Ong TA
  A review on the accuracy of bladder cancer detection methods. J Cancer. 2019 Jul 8;10(17):4038-4044. doi: 10.7150/jca.28989. eCollection 2019.

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

Details for clinical trial NCT05324033